These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9509271)

  • 21. SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes.
    Wenzlau JM; Moua O; Sarkar SA; Yu L; Rewers M; Eisenbarth GS; Davidson HW; Hutton JC
    Ann N Y Acad Sci; 2008 Dec; 1150():256-9. PubMed ID: 19120307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetes.
    Hoppu S; Härkönen T; Ronkainen MS; Akerblom HK; Knip M;
    J Autoimmun; 2004 Dec; 23(4):361-70. PubMed ID: 15571930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New predictors of disease. Molecules called predictive autoantibodies appear in the blood years before people show symptoms of various disorders. Tests that detected these molecules could warn of the need to take preventive action.
    Notkins AL
    Sci Am; 2007 Mar; 296(3):72-9. PubMed ID: 17348162
    [No Abstract]   [Full Text] [Related]  

  • 24. [The prevention of insulin-dependent diabetes mellitus].
    Loureiro MM; Duarte R; Boavida JM; Lisboa PE
    Acta Med Port; 1996; 9(10-12):353-60. PubMed ID: 9254534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes.
    Hoppu S; Ronkainen MS; Kimpimäki T; Simell S; Korhonen S; Ilonen J; Simell O; Knip M
    Pediatr Res; 2004 Feb; 55(2):236-42. PubMed ID: 14605243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Etiology and pathogenesis of type I diabetes].
    Ziegler AG
    Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of type 1 diabetes: the time has come.
    Sherr J; Sosenko J; Skyler JS; Herold KC
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):334-43. PubMed ID: 18446141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological and ethical consiluations on trials with immunotherapy in pre-type 1 (insulin-dependent) diabetes mellitus.
    Dahlqvist G
    Diabetologia; 1991 Jul; 34(7):536. PubMed ID: 1916062
    [No Abstract]   [Full Text] [Related]  

  • 29. [Is prevention of type I diabetes mellitus feasible?].
    Thivolet C
    Diabete Metab; 1994; 20(2 Pt 2):235-9. PubMed ID: 8001710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family studies of insulin-dependent diabetes: the UK experience.
    Gale EA; Bingley PJ; Tarn AC
    Adv Exp Med Biol; 1988; 246():229-33. PubMed ID: 3074655
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GAD antibody in multiplex diabetic pedigrees of Chinese.
    Chen T; Ren Y; Long Y; Zhang X; Yu H; Tian H
    Diabetes Care; 2007 Dec; 30(12):3091-2. PubMed ID: 17878243
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunotherapy of type 1 diabetes].
    Timsit J; Boitard C; Bach JF
    Rev Prat; 1992 May; 42(9):1075-9. PubMed ID: 1496232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for preventing type I diabetes mellitus.
    Verge CF; Eisenbarth GS
    West J Med; 1996 Mar; 164(3):249-55. PubMed ID: 8775937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune intervention with anti-CD3 in diabetes.
    Harlan DM; von Herrath M
    Nat Med; 2005 Jul; 11(7):716-8. PubMed ID: 16015359
    [No Abstract]   [Full Text] [Related]  

  • 36. [Latent autoimmune diabetes in adults].
    Maioli M; Puddu L; Pes GM
    Clin Ter; 2006; 157(1):69-78. PubMed ID: 16669554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early detection of autoimmune diabetes mellitus].
    Amital-Teplizki H; Shoenfeld Y
    Harefuah; 1994 Feb; 126(4):211-4. PubMed ID: 8168767
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prediction and prevention of type 1 diabetes mellitus: initial results and recent prospects].
    Madácsy L
    Orv Hetil; 2011 Nov; 152(48):1916-21. PubMed ID: 22071294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
    Daw K; Ujihara N; Atkinson M; Powers AC
    J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.